Abbreviated AUC Monitoring of Cyclosporine More Adequately Identified Patients at Risk for Acute Rejection During Induction of Immunosuppressive Therapy After Kidney Transplantation Than Recommended C2 Concentration Values

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 127-130

  Troncoso, P ^a   Ortiz, A M ^a   Jara, A ^a   Vilches, S ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ACUTE GRAFT REJECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG MONITORING; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; AREA UNDER CURVE; CADAVER; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT SELECTION; RETROSPECTIVE STUDIES; TISSUE DONORS; YOUNG ADULT;

EID: 60649087796     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.11.002     Document Type: Article

References (10)

1. Johnston A., Sketris I., Marsden J.T., et al. A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 22 (1990) 1345
2. David O.J., and Johnston A. Limited sampling strategies for estimating cyclosporine area under the concentration-time curve: review of current algorithms. Ther Drug Monit 23 (2001) 100
3. Amante A.J., and Kahan B.D. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period. Transplant Proc 28 (1996) 2162
4. Levy G., Thervet E., Lake J., et al. Patient management by Neoral C2 monitoring: an international consensus statement. Transplantation 73 (2002) S12
5. Morris R.G., Russ G.R., Cervelli M.J., et al. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 24 (2002) 479
6. Martínez L., Velasco A., Foradori A., et al. Abbreviated AUC and average concentrations of cyclosporin (Neoral). Rev Chil Urol 62 (1997) 51
7. Park J.B., Han Y.S., Kim S.J., et al. Feasibility of C2 monitoring in Korean renal transplantation. Transplant Proc 39 (2007) 3105
8. Kahan B.D., Keown P., Levy G., et al. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 24 (2002) 330
9. Canadian Neoral Renal Transplantation Study Group. Absorption profiling of cyclosporine microemulsion (Neoral) during the first two weeks after renal transplantation. Transplantation 72 (2001) 1024
10. Le Meur Y., Büchler M., Thierry A., et al. Individualized mycophenolate mofetil dosing during exposure significantly improves patient outcomes after renal transplantation. Am J Transplant 7 (2007) 2496